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  THE SIMULTANEOUS SPECTROPHOTOMETRIC 
DETERMINATION OF TRIMAZOLIN AND 
PHENYLEPHRINE HYDROCHLORIDE IN 
NASAL PREPARATIONS 
This paper presents the experimental results for the simultaneous spectropho-
tometric determination of two active components in nasal solutions. The reso-
lution of two-component mixtures of timazolin and phenylephrine has been ac-
complished by using partial least-squares. The method comprised of the ab-
sorptivity measurement in a nasal solution at wavelengths of 265 and 272 nm, 
respectively. Notwithstanding the presence of two components and their high 
degree of spectral overlap, they have been determined simultaneously with 
high accuracy and precision, with no interference, rapidly and without resorting 
to extraction procedures using non aqueous solvents. This method was tested 
and validated for various parameters according to ICH guidelines. The results 
demonstrated that the procedure is accurate, precise and reproducible (rela-
tive standard deviation <2 %), while being simple, cheap and less time con-
suming. The metod was apllied for the analysis of these drug substances in 
their commercial pharmaceutical formulations. 
Key words: trimazolin hydrochloride; phenylephrine hydrochloride; vali-
dation. 
 
 
In practice, a great number of nasal prepara-
tions, which most often contain ephedrine and phenyl-
eprine as adrenergic vasoconstrictors, are commercially 
present today [1]. The subject of this paper is a de-
congestive preparation of Adrianol drops (Zdravlje-Ac-
tavis, Leskovac, Serbia). Besides phenylephrine, Ad-
rianol contains trimazolin hydrochloride as an adrene-
rgic vasoconstrictor. The efficiency of the preparation 
is increased by the use of trimazolin hydrochloride. 
Trimazolin hydrocloride (C13H19N2Cl, Mw = 238.76 
g mol
-1) or (2-(2,4,6-trimethylbenzyl)-imidazoline hyd-
rochloride or 2-(2,4,6-trimethylbenzyl)-1,3-diazacyclo-
penten-(2)-hydrochloride is an alpha-adrenergic (de-
congestant) agent which stimulates alpha-adrenergic 
receptors (Figure 1), producing pronounced vaso-
constriction [2]. It is a white, crystalline, almost odour-
less, bitter substance, freely soluble in water, slightly 
soluble in ethanol, insoluble in ether and acetone with 
the melting point of 279-281 °C. A 10 % aqueous so-
lution has a pH of about 5.5-6.5 [3]. 
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Figure 1. Chemical structure of trimazolin hydrochloride. 
The trimazolin–phenylephrine mixture is not yet 
official in any pharmacopoeia. The patent literature 
has data on only the trimazolin and trimazolin hydro-
chloride synthesis procedure, without physicochemi-
cal, spectroscopic characterization and other invest-
tigation methods [4]. To our knowledge, no analytical 
methods could be traced for the analysis of trimazolin 
hydrochloride or trimazolin–phenylephrine combina-
tion in a pharmaceutical dosage form. Therefore, a 
simple, rapid and reliable method for the simultane-
ous assay of both components in the mixture seemed 
to be necessary. The development of UV spectropho-
tometric methods can provide a very useful alterna-
tive for the routine analysis of nasal formulations. The 
objective of the present study was to develop simple, 
precise, accurate and economic analytical methods 
for the estimation of trimazolin hydrochloride and phe-
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maceutical formulations. The developed analytical 
method was validated as per ICH guidelines [5,6], 
and Serbian requirements [7]. Statistical tests were 
performed on validation data [8,9]. 
MATERIALS AND METHODS 
Apparatus 
A double-beam Varian Cary-100 Conc UV–Vis 
spectrophotometer connected to the computer and 
loaded with Cary WinUV software was used for all ab-
sorbance measurements and data treatment. The ins-
trument has an automatic wavelength accuracy of 0.1 
nm and matched quartz cells of the10 mm cell path 
length. 
Chemicals 
The standards of trimazolin hydrochloride (99.91 %) 
and phenylephrine hydrochloride (99.97 %) were ob-
tained as gift samples from the Pharmaceutical and 
Chemical Industry Zdravlje-Actavis (Leskovac, Ser-
bia), and used without further purification. All other 
chemicals and reagents used were of analytical grade 
(Merck Chem. Ind.). 
Pharmaceutical preparation 
A commercial pharmaceutical preparation for 
children, Adrianol-T nasal drops, labeled to contain 
0.5 mg cm
-3 of trimazolin hydrochloride and 0.5 mg 
cm
-3 of phenylephrine hydrochloride. Adrianol-T con-
tains excipients like disodium hydrophosphate dihyd-
rate, citric acid monohydrate, methyl cellulose M.H.B. 
10000, glycerol, phenyl-mercury (II) borate, ammo-
nium hydroxide, ethanol, 96 %, and pure water. 
Calibration graphs 
The first series of calibrated flasks contained a 
varying concentration of trimazolin hydrochloride (10- 
-60 µg cm
-3) and a constant concentration of phenyle-
phrine hydrochloride. The second series contained a 
varying concentration of phenylephrine hydrochloride 
(10-60 µg cm
-3) and a constant concentration of tri-
mazolin hydrochloride. Trimazolin hydrochloride and 
phenylephrine hydrochloride were estimated at 265 
and 272 nm in aqueous medium. 
Sample preparation 
The aliquot (1 cm
3) of Adrianol T equivalent to 
0.5 mg trimazolin hydrochloride and 0.5 mg of phe-
nylephrine hydrochloride was taken and suitably di-
luted with water to get a 50 µg cm
−3 concentration and 
the sample was analyzed using proposed analytical 
methods. 
Spectrophotometric measurements 
Absorbance ratio method 
Such a method of analysis is based on the linear 
relationship between the absorbance value of  a bi-
nary mixture and the relative concentration of such a 
mixture. The quantification analysis of trimazolin hyd-
rochloride and phenylephrine hydrochloride in the bi-
nary mixture is performed by using following 
equations (1) and (2): 
2 12 1 11 1 c f c f A + =  (1) 
2 22 1 21 2 c f c f A + =  (2) 
where:  A1 and A2 denotes the absorbances of the 
nasal solution (Adrianol T) measured at λ1 (265 nm) 
and λ2 (272 nm), c1 and c2 denotes the concentrations 
of trimazolin hydrochloride and phenylephrine hydro-
chloride, respectively. f11 and f12 denotes the slopes of 
regression equations of trimazolin hydrochloride and 
phenylephrine hydrochloride at λ1. f21 and f22 denotes 
the slopes of regression equations of trimazolin hyd-
rochloride and phenylephrine hydrochloride at λ2. 
RESULTS AND DISCUSSION 
The UV spectra of trimazolin and phenylephrine 
hydrochloride in the aquous medium and UV spec-
trum of Adrianol T are shown in Figure 2. 
In particular, the absorbance at 265 nm for tri-
mazolin hydrochloride and at 272 nm for phenyle-
phrine hydrochloride were considered as the optimum 
working wavelengths for their determination. The best 
linear response to analyte concentrations is achieved 
by using these wavelengths. The regression curve 
was calculated by the least-squares method. Beer’s 
law was obeyed in the concentration range from 10 to 
60 µg cm
-3 of trimazolin hydrochloride and phenyle-
phrine hydrochloride. 
The absorption spectra of trimazolin hydrochlo-
ride and phenylephrine hydrochloride were not chan-
ged in the presence of common excipients used in the 
pharmaceutical preparations. The calculated t-values 
were found to be (0.814 for trimazolin hydrochloride 
at 265 nm and 1.45 for phenylephrine hydrochloride 
at 275 nm) less than that of the tabulated t-values 
(2.225). Therefore, the proposed analytical method is 
specific and selective for the drug. 
The linearity range for trimazolin hydrochloride 
at 265 nm estimation was found to be 10–60 µg cm
-3 
(r = 0.9992) and 10–60 µg cm
-3 (r = 0.9993) for phe-
nylephrine hydrochloride at 275 nm. Goodness of the 
fit of the regression equations was supported by high 
regression coefficient values. The  accuracy ranged I. SAVIĆ et al.: THE SIMULTANEOUS SPECTROPHOTOMETRIC DETERMINATION…  CI&CEQ 14 (4) 261−264 (2008) 
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from 40 to 60 µg cm
-3. The excellent mean percent-
tage recovery values, close to 100 %, and their low 
standard deviation values (SD < 1.0) represent high 
accuracy of the analytical methods. The validity and 
reliability of the proposed methods was assessed by 
the recovery studies. The mean percenttage recove-
ries (RSD) for lower, intermediate and higher concen-
trations were found to be 99.63 (40 µg cm
-3), 99.50 
(50 µg cm
-3) and 100.08 (60 µg cm
-3) for trimazolin hyd-
rochloride and 100.57 (40 µg cm
-3), 99.60 (50 µg cm
-3) 
and 100.33 (60 µg cm
-3) for phenylephrine hydrochlo-
ride, respectively. The validity and reliability of the pro-
posed methods was further assessed by recovery stu-
dies via the standard addition method. The mean per-
centtage recoveries for the concentration from 50 µg 
cm
-3 were found to be 99.74 (0.58), 100.50 (0.64) and 
99.84 (0.53) for trimazolin hydrochloride and 100.53 
(0.61), 100.87 (0.49) and 99.04 (0.73) for phenyle-
phrine hydrochloride, respectively. These results re-
vealed that any small change in the drug concen-
tration in the solutions could be accurately determined 
by the proposed analytical methods. 
a) 
 
a) 
 
Figure 2. UV-absorption spectra of a) Adrianol (A) and Adrianol-
T (B) nasal drops preparation and b) excipiens of Adrianol T (A), 
trimazolin hydrohloride (B) and phenylephrine (C). 
The precision was determined by studying the 
repeatability and the intermediate precision. The re-
peatability (RSD) ranged from 40 to 60 µg cm
-3. The 
repeatability results indicated the precision under the 
same operating conditions over a short interval of 
time and the inter-assay precision. The intermediate 
precision expresses within-laboratory variations in dif-
ferent days and in different instruments. In the inter-
mediate precision study, RSD values were not more 
than 2.0 % in all the cases. RSD values found for the 
proposed analytical method were well within the acce-
ptable range indicating that the method has an excel-
lent repeatability and the intermediate precision. 
LOD and LOQ were found to be 2.758 and 
8.276 µg cm
-3 for trimazolin hydrocloride at 265 nm, 
and 2.54 and 7.62 µg cm
-3 for phenylephrine hydro-
cloride at 272 nm. 
By measuring the absorbance values at 265 nm 
(λmax for trimazolin hydrochloride ) and 272 nm (λmax 
for phenylephrine hydrochloride) in the nasal prepa-
ration (Adrianol T), the analysis of the binary mixture 
containing trimazolin hydrochloride and phenyle-
phrine hydrochloride were made by using formulas 
(Eqs. (1) and (2)). 
The assay values of trimazolin hydrochloride 
and phenylephrine hydrochloride in synthetic mixtures 
were found 100.50 and 100.12 %, respectively. The 
standard deviation was not more than 0.41 % for tri-
mazolin hydrochloride and 0.09 % for phenylephrine 
hydrochloride. 
The assay values of formulations were the same 
as mentioned in the label claim indicating that the 
interference of the excipient matrix is insignificant in 
the estimation of trimazolin hydrochloride and phe-
nylephrine hydrochloride by proposed analytical me-
thods. The estimated drug content with low values of 
the standard deviation established the precision of the 
proposed method. The calculated student’s t-values 
(1.38 of trimazolin hydrochloride and 1.09 of phenyle-
phrine hydrochloride) did not exceed the tabulated 
values (theoretical values at 95 % confidence limits is 
t =2.225). 
CONCLUSIONS 
The method proposed is simple, rapid and di-
rect. The sample recovery from the formulation was in 
good agreement with its respective label claim, which 
suggested non-interference of formulation excipients 
in the estimation.This paper demonstrates the poten-
tial of the spectroscopy method as an analytical tech-
nique and its usefulness to accurately, rapidly, simply 
and simultaneously quantitate the active ingredients I. SAVIĆ et al.: THE SIMULTANEOUS SPECTROPHOTOMETRIC DETERMINATION…  CI&CEQ 14 (4) 261−264 (2008) 
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in multicomponent pharmaceuticals. Moreover, the pre-
sent method is fast with respect to the analysis time 
as compared to sophisticated chromatographic tech-
niques. 
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